Abstract:The expanding gene‐editing toolbox has driven a biomedical revolution. These molecular tools tremendously contribute to the progression of fundamental research, such as epigenetics, drug development, disease modeling, and disease diagnosis. Furthermore, therapeutic gene editing offers a profound opportunity to improve the current treatment of human diseases. The expanding genome editing toolbox has revolutionized life science research ranging from the bench to the bedside. These "molecular scissors" have offered us unprecedented abilities to manipulate nucleic acid sequences precisely in living cells from diverse species. Continued advances in genome editing exponentially broaden our knowledge of human genetics, epigenetics, molecular biology, and pathology. Currently, gene editing‐mediated therapies have led to impressive responses in patients with hematological diseases, including sickle cell disease and thalassemia. With the discovery of more efficient, precise and sophisticated gene‐editing tools, more therapeutic gene‐editing approaches will enter the clinic to treat various diseases, such as acquired immunodeficiency sydrome (AIDS), hematologic malignancies, and even severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. These initial successes have spurred the further innovation and development of gene‐editing technology. In this review, we will introduce the architecture and mechanism of the current gene‐editing tools, including clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR‐associated nuclease‐based tools and other protein‐based DNA targeting systems, and we summarize the meaningful applications of diverse technologies in preclinical studies, focusing on the establishment of disease models and diagnostic techniques. Finally, we provide a comprehensive overview of clinical information using gene‐editing therapeutics for treating various human diseases and emphasize the opportunities and challenges.

Epigenome editing by CRISPR/Cas9 in clinical settings: possibilities and challenges.

Development and application of CRISPR/Cas9 technologies in genomic editing.

Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics

The power and the promise of CRISPR/Cas9 genome editing for clinical application with gene therapy

CRISPR/Cas9 therapeutics: progress and prospects

CRISPR/Cas9 for Genome Editing: Progress, Implications and Challenges.

Next-generation CRISPR technology for genome, epigenome and mitochondrial editing

Advances in CRISPR-Cas systems for epigenetics

CRISPR/Cas9‐mediated genome editing: From basic research to translational medicine

Molecular mechanisms, off‐target activities, and clinical potentials of genome editing systems

Recent Advances in Chemical Control of CRISPR/Cas9 Genome Editing Technology

Spatiotemporal control of CRISPR/Cas9 gene editing

Precision epigenetic editing: Technological advances, enduring challenges, and therapeutic applications

CRISPR-Cas Systems: Overview, Innovations and Applications in Human Disease Research and Gene Therapy

Current landscape of gene‐editing technology in biomedicine: Applications, advantages, challenges, and perspectives

Advances in targeting cancer epigenetics using CRISPR-dCas9 technology: A comprehensive review and future prospects

CRISPR technologies for genome, epigenome and transcriptome editing

Advances in the Engineering of the Gene Editing Enzymes and the Genomes: Understanding and Handling the Off-Target Effects of CRISPR/Cas9.

Advances in Therapeutic Application of CRISPR-Cas9

The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases

Current trends of clinical trials involving CRISPR/Cas systems